Optimum Medical Treatment
- Home
- Optimum Medical Treatment
“Quadruple Medical Therapy”
Current international guidelines recommend the combined use of four different drug classes in systolic heart failure. This combination both extends life expectancy and significantly reduces the risk of hospitalization.
Drug Class | How It Works? | Benefit |
|---|---|---|
ARNI (Sacubitril/Valsartan) | Reduces pressure on the heart, increases protective hormones | Reduces the risk of death by 20% |
Beta-Blocker | Regulates heart rate, protects the heart | Lowers the risk of sudden death |
MRA (Mineralocorticoid Antagonist) | Combats fluid retention, protects the heart against remodeling | Reduces hospitalization |
SGLT2 Inhibitor | Excretes harmful fluids and salts through the kidneys | Reduces cardiovascular death |
Important: These medications complement one another. They must be initiated under physician supervision, dosages should be titrated gradually, and they should never be stopped on your own.
This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.